Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Phenyl Versus Pyridyl Substituents as Molecular Switches for Cellular Toxicity and Cellular Localization in Tetraarylvinylthiophenes.

Chemistry, an Asian journal·2026
Same author

π-Spacer effects in 2,6-disubstituted BODIPY fluorophores for mitochondrial imaging.

Organic & biomolecular chemistry·2026
Same author

CAHNetF-DTP: A Community-Aware Heterogeneous Network-Based Embedding Framework for Drug-Target Interaction Prediction.

Journal of chemical information and modeling·2026
Same author

Comparison of Analgesic Efficacy of Hyperbaric Levobupivacaine With or Without Clonidine in Patients Undergoing Intramedullary Nailing for Fracture Femur Under Subarachnoid Block: A Randomised Controlled Trial.

Cureus·2026
Same author

Vasorelaxation and antihypertensive activity of standardized extract of Gymnema sylvestre in rodent model.

Fitoterapia·2026
Same author

DABCO-Catalyzed β-C(sp<sup>2</sup>)-H Indolylation of 4-Arylidene Pyrazolones and 5-Arylidene Thiazolones with <i>N</i>-Tosyliminoindoles.

The Journal of organic chemistry·2025
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Poonam Rani1, Nimisha Basavaraj2, Reddy Peera Kommaddi2

  • 1Indian Institute of Science, Bangalore, Karnataka, India.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

新的小分子激活蛋白质酶体 (UPS) 清除蛋白质聚合物,通过提高记忆力和减少斑块,为阿尔茨海默氏症等神经退行性疾病提供潜在的治疗方法.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 蛋白质稳定维护蛋白质组的稳定性通过诸如无素-蛋白质组系统 (UPS) 和自等系统.
  • 这些通路的与衰老相关的失调导致神经元蛋白质聚合,这是神经退行性疾病的标志.
  • 虽然蛋白质酶激活正在研究中,但UPS在清除聚合蛋白中的作用为阿尔茨海默氏症和其他错误折叠疾病提供了治疗目标.

研究的目的:

  • 合成和选基于新型氨酸和伊米达林的小分子以激活蛋白质酶.
  • 研究蛋白质酶激活的机制,包括结合点和分子相互作用.
  • 在神经退行性疾病的细胞和动物模型中评估这些化合物的治疗潜力.

主要方法:

  • 在SH-SY5Y神经母细胞瘤细胞中合成和选小分子.
  • 计算模拟 (对接,分子动力学) 来预测与蛋白质体的结合.
  • 在多个细胞系中进行体外蛋白活性测试和细胞活力测试.
  • 在APP/PS1阿尔茨海默病小鼠模型中的体内研究.

主要成果:

  • 小分子通过门打开机制选择性地结合并激活了蛋白质体.
  • 一种化合物表现出高效,在纳米分子度下激活蛋白酶体活性,没有观察到毒性.
  • 在阿尔茨海默氏症小鼠中,治疗减少了粉样蛋白质斑块,改善了记忆力,并恢复了蛋白质酶体功能.
  • 这些化合物在神经元细胞中提供了对氧化应激的神经保护.

结论:

  • 通过打开门直接激活蛋白酶是一种用于神经退行性疾病的新治疗策略.
  • 这种方法在细胞和动物模型中得到验证,可以减少粉样蛋白病理并增强神经保护.
  • 这些发现支持蛋白质酶激活剂的发展,作为一个有前途的治疗类.